Your English writing platform
Discover LudwigExact(27)
In the rat, the ability of drugs to lower brain stimulation reward (BSR) thresholds often correlates with high abuse liability.
Its paradoxically high abuse potential may reflect behavioral control by drug-associated stimuli, which appears to play a larger role for tobacco dependence than for other abused drugs.
A drug appearing on Schedule 1 "has high abuse potential, no accepted medical use and no accepted safety for use," the drug agency said.
MDMA has taboo associations with psychedelia and rave culture — it's classified as Schedule 1, reserved for illegal drugs with high abuse potential.
Thus, the results suggest that the rewarding effects of URB694 are weaker than cocaine or THC, and that URB694 would not have high abuse potential.
Marijuana and its components, including CBD, are Schedule 1 controlled substances — meaning they are banned because they are thought to have a high abuse potential, no medical value and serious safety implications.
Similar(33)
Specifically, DSM-IV inhalant abuse and dependence diagnoses did not appear to divide problem inhalant users into discrete groups with high abuse-low dependence and low abuse-high dependence symptom profiles.
The Philippines has the highest abuse rate in East Asia for methamphetamines, known locally as shabu.
"Opioid drugs have a higher abuse liability the faster they get into the brain," Doberstein says.
Schedule III drugs are easier for doctors to prescribe and for patients to refill than those considered to pose the highest abuse risk, which are placed in Schedule II.
Whilst higher abuse concentrations triggered the need for attention to prevention in these locations, it is the features of the abuse in each context that informs the prevention approach to be undertaken.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com